中康控股(02361.HK)推出“醫療健康全場景智能體”：以AI技術賦能醫療產業新變革
格隆匯3月16日丨中康控股(02361.HK)發佈公吿，廣州中康數字科技有限公司(“中康科技”)(集團的間接全資附屬公司)推出“醫療健康全場景智能體”(“智能體”)，一套以人工智慧(AI)技術為核心、通過數智化手段提升醫療健康產業效率的創新解決方案。
智能體依託中康科技的兩大核心引擎－“天宮一號”商用引擎和“卓睦鳥”醫療引擎－構築卓睦鳥醫療大模型作為技術基座，結合行業高質量數據、專業知識和領先的大模型蒸餾技術，打造了覆蓋商用、醫療、藥店、健康管理和研發五大場景的數智化解決方案。
醫療健康全場景智能體包括：1.醫療智能體：通過多模態資料分析(影像、病理等)，輔助醫生提升診斷效率與精準度，為複雜病例提供即時決策支持，同時幫助醫生提高科研效率；2.藥店智能體：向消費者輸出個性化專業服務解決方案，同時優化連鎖藥店庫存與運營效率，助力銷售增長；3.商用智能體：整合內外部資料與政策動態，全面掌握市場動態，並據此敏捷生成精準策略並輔助實施，支持醫藥企業快速回應市場變化；4.健康管理智能體：打破醫療健康服務主體之間的壁壘，為用户提供全生命週期健康管理服務，提升就醫體驗與健康管理水準；及5.研發智能體：加速新藥研發週期，通過AI模擬藥物療效與臨牀試驗，縮短研發週期，降低研發成本。
五大智能體協同運作，不僅推動行業效率躍升，更將患者端、企業端與醫療機構的需求深度聯結，形成“技術－產業－用户”三位一體的價值網路。目前，中康科技已與多家三甲醫院、頭部藥企及連鎖藥店達成合作，推動智能體在真實場景中快速落地。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
